drugset / Trial / NCT06820645

Calcium Administration in Life-saving Management During Massive Hemorrhage

NCT06820645

RandomizedParallel-groupQuadruple-blindOther

Summary

This study evaluates the feasibility of conducting a larger study on the impact of treating massive hemorrhage with calcium in trauma patients. Patients undergoing the Massive Hemorrhage Protocol (MHP) will be randomly assigned to receive either calcium gluconate or placebo drug after every 4 packs of units of RBCs received during the MHP.

Timeline

Start
2025-05-01
Primary completion
2026-04-30
Completion
2026-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject calcium gluconate Small molecule 3 g Intravenous

Indications

No indication recorded.